Skip to content

Natural Cycle In Vitro Fertilization

Natural Cycle In Vitro Fertilization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01866618
Enrollment
524
Registered
2013-05-31
Start date
2013-04-30
Completion date
2016-12-31
Last updated
2018-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Natural Cycle in Vitro Fertilization (IVF)

Keywords

Natural, IVF Cycle

Brief summary

Natural IVF study patients will undergo an IVF cycle with trigger shots of Lupron & hCG. Patients will not be given any other stimulating medications during the cycle. They will have 2 uterine aspirations and an endometrial biopsy at designated times. The first uterine aspiration will be randomized to one of four days (day before retrieval, day of retrieval, day after retrieval or 2 days after retrieval). The second uterine aspiration and endometrial biopsy will be performed 6 days after retrieval. Any embryo(s) obtained will be biopsied for Comprehensive Chromosome Screening (CCS) and frozen for use in a subsequent thaw cycle.

Interventions

None listed

Sponsors

Reproductive Medicine Associates of New Jersey
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Ovulatory cycles every 39 days or less (natural cycle IVF cannot be performed in someone who does not have cycles) * Must be RMANJ patient and have completed all diagnostic screening at one of our RMANJ locations. All diagnostic screening is NOT covered under the study and must be completed prior to being allowed to start the study cycle.

Exclusion criteria

* Prior enrollment/attempt in this study * Requirement for surgical sperm extraction * Inability to assess ovaries via transvaginal ultrasound * Inability to tolerate vaginal examination

Design outcomes

Primary

MeasureTime frameDescription
Endometrial Changes1 YearTo examine the endometrium within the natural cycle in order to accurately characterize the differences in multiple aspects of endocrine and paracrine hormonal activity, the transcriptome of cells influencing oocyte maturation and changes in the endometrium.

Secondary

MeasureTime frameDescription
Aneuploidy Rates1 YearTo examine aneuploidy rates in embryos from natural IVF cycles.

Other

MeasureTime frameDescription
Temporal Embryonic Development1 YearTo examine the parameters of temporal embryonic development and the transcriptome of granulosa cells and follicular fluid. The embryos will be graded at standard time points to determine whether there are differences in in vitro development. Granulosa cells and follicular fluid will undergo gene expression analysis and compared to the gene expression profiles found in those specimens in stimulated cycles.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026